Table Of Contents
1 Introduction 22
1.1 Objectives Of The Study 22
1.2 Market Definition 22
1.3 Overview Of Asia-Pacific Antimicrobial Susceptibility Testing Market 22
1.4 Currency And Pricing 23
1.5 Limitation 23
1.6 Markets Covered 24
2 Market Segmentation 26
2.1 Markets Covered 26
2.2 Geographic Scope 27
2.3 Years Considered For The Study 28
2.4 Currency And Pricing 28
2.5 Research Methodology 29
2.6 Primary Interviews With Key Opinion Leaders 32
2.7 The Category Vs Time Grid 33
2.8 DBMR Market Challenge Matrix 34
2.9 Secondary Sources 35
2.10 Assumptions 35
3 Market Overview 36
3.1 Drivers 38
3.1.1 Increase In Number Of Infectious Disease 38
3.1.2 Technological Advancements In Antimicrobial Susceptibility Methods 39
3.1.3 Emergence Of Multidrug Resistance Due To Multiple Drug Use 40
3.1.4 Increased Funding, Research Grants, And Public-Private Investments 41
3.2 Restraints 42
3.2.1 High Cost Of Automated Antimicrobial Susceptibility Testing Systems 42
3.3 Opportunities43
3.3.1 Emerging Markets To Offer Lucrative Opportunities 43
3.3.2 Increase Awareness To Detect And Control Antimicrobial Resistance 44
3.4 Challenges 45
3.4.1 Lack Of Coordination Between Regulatory Bodies, Clinical Laboratories, And Ast Manufacturers 45
4 Executive Summary 46
5 Premium Insights 48
6 Asia-Pacific Antimicrobial Susceptibility Testing Market, By Product 50
6.1 Overview 51
6.2 Manual 53
6.2.1 Susceptibility Testing Disks 54
6.2.2 Mic Strips 55
6.2.3 Susceptibility Plates 55
6.2.4 Antimicrobial Susceptibility Testing Culture Media 56
6.2.5 Consumables 56
6.3 Automated 57
6.3.1 Susceptibility Plates 58
6.3.2 Automated Instruments 59
6.3.3 Susceptibility Plate Ancillaries 59
7 Asia-Pacific Antimicrobial Susceptibility Testing Market, By Methods 60
7.1 Overview 61
7.2 Dilution Methods 62
7.3 Disk Diffusion Method 63
7.4 E- Test 64
7.5 Genotypic Methods 66
7.6 Automated Systems 67
8 Asia-Pacific Antimicrobial Susceptibility Testing Market, By Application 68
8.1 Overview 69
8.2 Clinical Diagnostics 70
8.3 Drug Discovery And Development 71
8.4 Epidemiology 72
8.5 Others 74
9 Asia-Pacific Antimicrobial Susceptibility Testing Market, By End User 75
9.1 Overview 76
9.2 Hospitals 78
9.3 Pharmaceutical And Biotechnology Companies 80
9.4 Diagnostic Laboratories 81
9.5 Research And Academic Institutes 82
9.6 Contract Research Organizations 83
?
10 Asia-Pacific Antimicrobial Susceptibility Testing Market, By Geography 84
10.1 Asia-Pacific 84
10.1.1 Japan 91
10.1.2 China 95
10.1.3 India 99
10.1.4 South Korea 103
10.1.5 Australia 107
10.1.6 Singapore 111
10.1.7 Thailand 115
10.1.8 Malaysia 119
10.1.9 Indonesia 123
10.1.10 Philippines 127
10.1.11 Rest Of Asia-Pacific 131
11 Asia-Pacific Antimicrobial Susceptibility Testing Market,
Company Landscape 132
11.1 Company Share Analysis; Asia-Pacific 132
12 Company Profiles 133
12.1 Biom?rieux Sa Company 133
12.1.1 Overview 133
12.1.2 Revenue Analysis 133
12.1.3 Company Share Analysis 134
12.1.4 Product Portfolio 134
12.1.5 Recent Developments 135
12.2 Thermo Fisher Scientific Inc. 137
12.2.1 Company Overview 137
12.2.2 Revenue Analysis 137
12.2.3 Company Share Analysis 138
12.2.4 Product Portfolio 138
12.2.5 Recent Developments 141
12.3 Bd 142
12.3.1 Company Overview 142
12.3.2 Revenue Analysis 142
12.3.3 Company Share Analysis 143
12.3.4 Product Portfolio 143
12.3.5 Recent Developments 144
?
12.4 Accelerate Diagnostics, Inc. 146
12.4.1 Company Overview 146
12.4.2 Revenue Analysis 146
12.4.3 Product Portfolio 146
12.4.4 Recent Developments 147
12.5 Alifax Holding S.P.A. 148
12.5.1 Company Overview 148
12.5.2 Geographic Presence 148
12.5.3 Product Portfolio 149
12.5.4 Recent Developments 149
12.6 Bio-Rad Laboratories Inc. 150
12.6.1 Company Overview 150
12.6.2 Revenue Analysis 150
12.6.3 Product Portfolio 151
12.6.4 Recent Developments 151
12.7 Bioanalyse Tibbi Malz. San. Ve Tic. Ltd. Sti. 152
12.7.1 Company Overview 152
12.7.2 Product Portfolio 152
12.7.3 Recent Developments 152
12.8 Conda 153
12.8.1 Company Overview 153
12.8.2 Geographic Presence 153
12.8.3 Product Portfolio 154
12.8.4 Recent Developments 155
12.9 Creative Diagnostics 156
12.9.1 Company Overview 156
12.9.2 Geographic Presence 156
12.9.3 Product Portfolio 157
12.9.4 Recent Developments 157
12.10 Genefluidics Inc.158
12.10.1 Company Overview 158
12.10.2 Product Portfolio 158
12.10.3 Recent Developments 158
12.11 Himedia Laboratories 159
12.11.1 Company Overview 159
12.11.2 Geographic al Presence 159
12.11.3 Product Portfolio 160
12.11.4 Recent Developments 161
?
12.12 Liofilchem Srl. 162
12.12.1 Company Overview 162
12.12.2 Product Portfolio 162
12.12.3 Recent Developments 163
12.13 Merck Millipore 164
12.13.1 Company Overview 164
12.13.2 Geographic Presence 164
12.13.3 Product Portfolio 165
12.13.4 Recent Developments 165
12.14 Zhuhai Dl Biotech. Co., Ltd 166
12.14.1 Company Overview 166
12.14.2 Product Portfolio 166
12.14.3 Recent Developments 166
13 Related Reports 167
?